glycyrrhizic acid has been researched along with ursodeoxycholic acid in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Arase, Y; Chayama, K; Ikeda, K; Kobayashi, M; Kumada, H; Murashima, N; Saitoh, S; Suzuki, Y; Tsubota, A | 1 |
| Amagaya, S; Fukuda, K; Ishige, A; Ito, T; Komatsu, Y; Miura, N; Ohtake, N; Sasaki, H; Terasawa, K; Yamamoto, M | 1 |
| Harada, H; Kamitsukasa, H; Kojima, H; Murai, S; Tokita, H; Yagura, M | 1 |
| Kasahara, A | 1 |
| Ishikawa, H; Kakisaka, Y; Kashima, K; Mitsuyoshi, H; Nakajima, Y; Nakamura, H; Nakashima, T; Sumida, Y; Yodoi, J; Yoh, T | 1 |
| Goto, T; Kato, J; Kato, N; Moriyama, M; Omata, M; Shiratori, Y; Taniguchi, H | 1 |
| Fujiyama, S; Hirokawa, S; Masaki, T; Miyakawa, K; Ohkawa, S; Tamai, S; Tanaka, K; Tarao, K | 1 |
| Carreño, V | 1 |
| Matsumura, H; Matsuoka, S; Moriyama, M; Nakamura, H; Nirei, K | 1 |
| Chou, ST; Ho, TY; Hsiang, CY; Kao, ST; Lin, LJ; Lo, HY | 1 |
| Alves, K; Badri, PS; Ding, B; Dutta, S; Menon, RM; Redman, R; Rodrigues, L; Uchiyama, N; Zha, J | 1 |
| Horikiri, T; Kaneko, Y; Kinoshita, A; Kurita, Y; Kuwano, K; Odashima, K; Saito, Z; Seki, A; Seki, Y; Takeda, H; Yoshii, Y | 1 |
| Mehtiyev, SN; Mehtiyeva, OA | 1 |
| Aithal, GP; Alvarez-Alvarez, I; Andrade, RJ; Arikan, C; Atallah, E; Lucena, MI; Medina-Caliz, I; Niu, H | 1 |
4 review(s) available for glycyrrhizic acid and ursodeoxycholic acid
| Article | Year |
|---|---|
Treatment strategies for chronic hepatitis C virus infection.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Carcinoma, Hepatocellular; Drugs, Chinese Herbal; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Interferons; Iron Overload; Liver Neoplasms; Ribavirin; Treatment Outcome; Ursodeoxycholic Acid | 2000 |
Review article: management of chronic hepatitis C in patients with contraindications to anti-viral therapy.
Topics: Animals; Antiviral Agents; Biological Products; Contraindications; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Interferons; Iron; Ursodeoxycholic Acid | 2014 |
[[New Paradigm Challenges of Steatosis Treatment in the Practice Therapist].]
Topics: Adult; Drug Combinations; Fatty Liver; Glycyrrhizic Acid; Humans; Liver Cirrhosis; Liver Function Tests; Male; Phosphatidylcholines; Practice Patterns, Physicians'; Treatment Outcome; Ultrasonography; Ursodeoxycholic Acid | 2016 |
Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review.
Topics: Acetaminophen; Acetylcysteine; Adolescent; Adrenal Cortex Hormones; Adult; Carnitine; Chemical and Drug Induced Liver Injury; Child; Drug-Related Side Effects and Adverse Reactions; Glutathione; Glycyrrhizic Acid; Humans; Infant, Newborn; Liver; Liver Failure, Acute; Retrospective Studies; S-Adenosylmethionine; Ursodeoxycholic Acid | 2022 |
2 trial(s) available for glycyrrhizic acid and ursodeoxycholic acid
| Article | Year |
|---|---|
Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients.
Topics: Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Aspartate Aminotransferases; Cholagogues and Choleretics; Drug Therapy, Combination; Female; gamma-Glutamyltransferase; Glycyrrhizic Acid; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Prospective Studies; Regression Analysis; Time Factors; Treatment Outcome; Ursodeoxycholic Acid; Viremia | 1999 |
Incidence of hepatocellular carcinoma reduced by phlebotomy treatment in patients with chronic hepatitis C.
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Female; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Phlebotomy; Platelet Count; Ursodeoxycholic Acid | 2015 |
8 other study(ies) available for glycyrrhizic acid and ursodeoxycholic acid
| Article | Year |
|---|---|
Genipin, a metabolite derived from the herbal medicine Inchin-ko-to, and suppression of Fas-induced lethal liver apoptosis in mice.
Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Cells, Cultured; Cholagogues and Choleretics; fas Receptor; Female; Glycyrrhizic Acid; Intracellular Membranes; Iridoid Glycosides; Iridoids; Liver; Membrane Potentials; Mice; Mice, Inbred BALB C; Mitochondria, Liver; Permeability; Plants, Medicinal; Pyrans; Ursodeoxycholic Acid | 2000 |
Changes of liver fibrosis in chronic hepatitis C patients with no response to interferon-alpha therapy: including quantitative assessment by a morphometric method.
Topics: Alanine Transaminase; Antiviral Agents; Biomarkers; Biopsy; Disease Progression; Drugs, Chinese Herbal; Female; Glycyrrhizic Acid; Hepatitis C; Hepatitis C, Chronic; Humans; Injections, Intramuscular; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Peptide Fragments; Procollagen; Retrospective Studies; RNA, Viral; Ursodeoxycholic Acid | 2000 |
Thioredoxin levels in the sera of untreated viral hepatitis patients and those treated with glycyrrhizin or ursodeoxycholic acid.
Topics: Adult; Aged; Case-Control Studies; Female; Glycyrrhizic Acid; Hepatitis B; Hepatitis C; Humans; Indocyanine Green; Lipid Peroxides; Male; Middle Aged; Oxidative Stress; Thioredoxins; Ursodeoxycholic Acid | 2000 |
Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
Topics: Anti-Infective Agents; Antiviral Agents; Autoantigens; Blotting, Western; Cholagogues and Choleretics; Encephalomyocarditis virus; Foot-and-Mouth Disease Virus; Glucocorticoids; Glycyrrhizic Acid; Hepacivirus; Humans; Interferons; Methylprednisolone; Protein Biosynthesis; Ribavirin; Ribonucleoproteins; Ribosomes; RNA, Double-Stranded; RNA, Viral; SS-B Antigen; Tumor Cells, Cultured; Ursodeoxycholic Acid | 2002 |
Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Topics: Alanine Transaminase; Analysis of Variance; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Cholagogues and Choleretics; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Glycyrrhizic Acid; Hepacivirus; Hepatitis C; Humans; Incidence; Inflammation; Liver Cirrhosis; Liver Neoplasms; Logistic Models; Male; Middle Aged; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid | 2005 |
Glycyrrhizin, silymarin, and ursodeoxycholic acid regulate a common hepatoprotective pathway in HepG2 cells.
Topics: Apoptosis; Gene Expression Regulation; Glycyrrhizic Acid; Hep G2 Cells; Humans; Liver; NF-kappa B; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Protective Agents; Silymarin; Transcriptome; Ursodeoxycholic Acid | 2015 |
Drug Interactions Between Hepatoprotective Agents Ursodeoxycholic Acid or Glycyrrhizin and Ombitasvir/Paritaprevir/Ritonavir in Healthy Japanese Subjects.
Topics: Adult; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Japan; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Proline; Ritonavir; Sulfonamides; Ursodeoxycholic Acid; Valine; Young Adult | 2015 |
Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis.
Topics: Adult; Aged; Alanine Transaminase; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cysteine; Drug Combinations; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Humans; Liver; Male; Middle Aged; Retrospective Studies; Risk Factors; Tuberculosis; Ursodeoxycholic Acid; Young Adult | 2016 |